ACI Formulations Balance Sheet Health
Financial Health criteria checks 3/6
ACI Formulations has a total shareholder equity of BDT3.1B and total debt of BDT2.8B, which brings its debt-to-equity ratio to 90.5%. Its total assets and total liabilities are BDT7.1B and BDT4.0B respectively. ACI Formulations's EBIT is BDT526.2M making its interest coverage ratio 2.6. It has cash and short-term investments of BDT207.5M.
Key information
90.5%
Debt to equity ratio
৳2.84b
Debt
| Interest coverage ratio | 2.6x |
| Cash | ৳207.54m |
| Equity | ৳3.14b |
| Total liabilities | ৳4.00b |
| Total assets | ৳7.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACIFORMULA's short term assets (BDT4.6B) exceed its short term liabilities (BDT3.7B).
Long Term Liabilities: ACIFORMULA's short term assets (BDT4.6B) exceed its long term liabilities (BDT288.3M).
Debt to Equity History and Analysis
Debt Level: ACIFORMULA's net debt to equity ratio (83.9%) is considered high.
Reducing Debt: ACIFORMULA's debt to equity ratio has increased from 79.6% to 90.5% over the past 5 years.
Debt Coverage: ACIFORMULA's debt is well covered by operating cash flow (39%).
Interest Coverage: ACIFORMULA's interest payments on its debt are not well covered by EBIT (2.6x coverage).